Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-04

Clinical Trial Update: Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing blood pressure control with nifedipine GITS 60 mg in Chinese hypertensive patients uncontrolled on starting-dose mono-therapy; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine GITS (nifedipine)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 4 | Status: COMPLETED